4
MARKET OVERVIEW
Emerging markets drive neurovascular growth amid skilled surgeon shortage and high surgery costs.
44
4.2.1.1
INCREASE IN INCIDENCE OF NEUROVASCULAR DISEASES
4.2.1.2
AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR NEUROVASCULAR PROCEDURES
4.2.1.3
EXPANSION OF HEALTHCARE INFRASTRUCTURE ACROSS EMERGING ECONOMIES
4.2.1.4
RISE IN DEMAND FOR EFFECTIVE NEUROVASCULAR TECHNOLOGIES
4.2.2.1
DEARTH OF SKILLED NEUROSURGEONS
4.2.2.2
HIGH PROCEDURAL COST OF NEUROVASCULAR SURGERIES AND ASSOCIATED PRODUCTS
4.2.3.1
ADVANCEMENT OF AI- AND ROBOT-ASSISTED SYSTEMS FOR NEXT-GENERATION NEUROINTERVENTIONS
4.2.4.1
STRINGENT REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
4.3
UNMET NEEDS AND WHITE SPACES
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive dynamics and pricing shifts in the evolving neurovascular devices market landscape.
51
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
THREAT OF NEW ENTRANTS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN NEUROVASCULAR DEVICES MARKET
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY DISEASE PATHOLOGY
5.6.2
AVERAGE SELLING PRICE TREND OF NEUROVASCULAR DEVICES, BY REGION
5.7.1
IMPORT DATA FOR HS CODE 901890, 2020–2024
5.7.2
EXPORT DATA FOR HS CODE 901890, 2020–2024
5.8
KEY CONFERENCES & EVENTS, 2025–2026
5.9
TRENDS/DISRUPTIONS IMPACTING CONSUMERS’ BUSINESSES
5.10
INVESTMENT & FUNDING SCENARIO
5.11.1
FLOW DIVERTER FOR COMPLEX INTRACRANIAL ANEURYSMS
5.11.2
ADVANCED FLOW DIVERTER WITH ENHANCED DELIVERABILITY
5.11.3
STENT RETRIEVER THROMBECTOMY FOR ACUTE IN-STENT THROMBOSIS
5.12
IMPACT OF 2025 US TARIFFS ON NEUROVASCULAR DEVICES MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES AND REGIONS
5.12.5
IMPACT ON END-USER INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
AI-driven innovations are revolutionizing neurovascular devices, with patents and real-world applications leading market disruption.
71
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
NEGATIVE PRESSURE CLOT REMOVAL TECHNOLOGY
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
DIGITAL HEALTH AND REMOTE MONITORING PLATFORMS
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.3.1
SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2
MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION
6.3.3
LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4.1
PATENT PUBLICATION TRENDS FOR NEUROVASCULAR DEVICES MARKET
6.4.2
JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN NEUROVASCULAR DEVICES MARKET
6.4.3
LIST OF MAJOR PATENTS
6.5
IMPACT OF AI/GEN AI ON NEUROVASCULAR DEVICES MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
TOP CASE STUDIES OF AI IMPLEMENTATION IN NEUROVASCULAR DEVICES MARKET
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NEUROVASCULAR DEVICES MARKET
6.6
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
6.6.1
RAPID MEDICAL – AI-POWERED ROBOTIC THROMBECTOMY
6.6.2
AIDOC – AI IMAGING & STROKE WORKFLOW ACCELERATION
6.6.3
RAPIDAI – AI-DRIVEN NEUROVASCULAR IMAGING
7
REGULATORY LANDSCAPE
Navigate complex global regulations with regional insights and compliance strategies across key markets.
79
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
7.2.1
CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN NEUROVASCULAR DEVICES MARKET
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock hidden profitability by navigating stakeholder influence and unmet needs in buyer behavior.
85
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2
KEY BUYING CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS IN END USERS
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9
NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 32 Data Tables
91
9.2.2
BARE DETACHABLE COILS
9.2.2.1
SIGNIFICANT ADOPTION OF BARE DETACHABLE COILS BY NEUROSURGEONS FOR BRAIN ANEURYSM TREATMENT TO PROMOTE GROWTH
9.2.3
COATED DETACHABLE COILS
9.2.3.1
HIGH COST OF COATED DETACHABLE COILS TO LIMIT ADOPTION
9.2.4
FLOW DIVERSION DEVICES
9.2.4.1
RISING R&D ACTIVITIES TO DEVELOP NOVEL FLOW DIVERSION DEVICES TO PROMOTE GROWTH
9.2.5
INTRACRANIAL STENTS
9.2.5.1
INCREASED EFFICACY OF STENT-ASSISTED COILING FOR TREATMENT OF WIDE-NECKED INTRACRANIAL ANEURYSMS TO BOOST ADOPTION
9.3.1
CLOT RETRIEVER DEVICES
9.3.1.1
PROVEN CLINICAL EFFECTIVENESS IN TREATING LARGE CLOTS AND INCREASE IN NUMBER OF CLINICAL TRIALS AIMED AT VALIDATING THEIR USE IN ISCHEMIC STROKE TREATMENT TO DRIVE MARKET
9.3.2
SUCTION & ASPIRATION DEVICES
9.3.2.1
RAPID COMMERCIALIZATION OF TECHNOLOGICALLY ADVANCED ASPIRATION DEVICES FOR ISCHEMIC STROKE TREATMENT TO SUPPORT MARKET
9.3.3.1
LIMITED PROCEDURAL BENEFITS IN STROKE TREATMENT TO LIMIT ADOPTION OF VASCULAR SNARES
9.3.4.1
GROWING RECOGNITION OF BENEFITS ASSOCIATED WITH BALLOON CATHETERS TO BOLSTER DEMAND
9.4
CAROTID ARTERY STENOSIS
9.4.1
CAROTID ARTERY STENTS
9.4.1.1
GROWING ADOPTION OF CAROTID ARTERY STENTS FOR CAROTID INTERVENTION PROCEDURES TO SUPPORT GROWTH
9.4.2
EMBOLIC PROTECTION DEVICES
9.4.2.1
GROWING UTILIZATION OF DISTAL FILTERS DURING CAROTID INTERVENTION PROCEDURES TO PROMOTE GROWTH
9.4.3.1
GROWING PREFERENCE FOR BALLOON CATHETERS TO IMPROVE EFFICACY OF CAROTID INTERVENTION PROCEDURES TO AUGMENT GROWTH
9.5
ARTERIOVENOUS MALFORMATION & FISTULAS
9.5.1
LIQUID EMBOLIC AGENTS
9.5.1.1
DEVELOPMENT OF NOVEL LIQUID EMBOLIC AGENTS OFFERING HIGH EMBOLIZATION OF ARTERIOVENOUS FISTULAS TO SUPPORT GROWTH
9.5.2
OCCLUSION BALLOON CATHETERS
9.5.2.1
GROWING UTILIZATION OF BALLOON CATHETERS FOR AVM TREATMENT TO SUPPORT GROWTH
9.5.3.1
IMPROVED COMPATIBILITY OF MICROCATHETERS WITH EMBOLIC AGENTS TO BOOST DEMAND
9.6
OTHER DISEASE PATHOLOGIES
10
NEUROVASCULAR DEVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
113
10.2
HOSPITALS AND AMBULATORY SURGICAL CENTERS
10.2.1
INCREASING VOLUME OF NEUROVASCULAR PROCEDURES DUE TO AVAILABILITY OF ADVANCED EQUIPMENT TO DRIVE MARKET
10.3.1
INCREASE IN NEUROVASCULAR DISEASES TO DRIVE MARKET
10.4
RESEARCH AND ACADEMIC INSTITUTES
10.4.1
INCREASING COLLABORATIONS FOR DEVELOPMENT OF TECHNOLOGICALLY ADVANCED NEUROVASCULAR DEVICES TO SUPPORT MARKET GROWTH
11
NEUROVASCULAR DEVICES MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 174 Data Tables.
117
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2.1
PRESENCE OF ESTABLISHED NEUROVASCULAR DEVICE MANUFACTURERS TO DRIVE MARKET
11.2.3.1
LARGE TARGET POOL FOR ISCHEMIC STROKE PATIENTS TO DRIVE MARKET
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2.1
RISING GERIATRIC POPULATION TO DRIVE MARKET
11.3.3.1
GROWING PREFERENCE FOR MINIMALLY INVASIVE NEUROVASCULAR PROCEDURES TO DRIVE MARKET
11.3.4.1
RISING PREVALENCE OF STROKE TO DRIVE MARKET
11.3.5.1
INCREASING GERIATRIC POPULATION TO DRIVE DEMAND FOR NEUROVASCULAR DEVICES
11.3.6.1
RISING STROKE BURDEN AND STRONG HEALTHCARE INVESTMENT TO DRIVE DEMAND FOR NEUROVASCULAR DEVICES MARKET
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2.1
INCREASE IN HEALTHCARE SPENDING TO DRIVE MARKET
11.4.3.1
ROBUST PRESENCE OF NEUROVASCULAR DEVICE MANUFACTURERS TO DRIVE MARKET
11.4.4.1
INCREASE IN PREVALENCE OF NEUROVASCULAR DISEASES TO DRIVE UPTAKE FOR NEUROVASCULAR DEVICES
11.4.5.1
RISE IN INCIDENCE OF CEREBROVASCULAR DISEASE TO DRIVE MARKET
11.4.6.1
HEALTH INSURANCE COVERAGE FOR NEUROVASCULAR PROCEDURES TO SUPPORT MARKET GROWTH
11.4.7
REST OF ASIA PACIFIC
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2.1
INCREASING AWARENESS INITIATIVES ON STROKE SYMPTOMS TO DRIVE MARKET
11.5.3.1
INCREASING NEUROVASCULAR DISEASES TO SUPPORT MARKET GROWTH
11.5.4
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.6.1
MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA
11.6.2
SHORTAGE OF NEUROSURGEONS AND POOR HEALTHCARE COVERAGE TO RESTRAIN MARKET GROWTH
11.6.3.1
RISING STROKE PREVALENCE TO DRIVE NEUROVASCULAR DEVICES MARKET IN GCC COUNTRIES
11.6.4
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
Discover strategic moves and market dominance of neurovascular device leaders and emerging innovators.
196
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1
OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NEUROVASCULAR DEVICES MARKET
12.4
MARKET SHARE ANALYSIS, 2024
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1
COMPANY FOOTPRINT
12.5.5.2
REGIONAL FOOTPRINT
12.5.5.3
DISEASE PATHOLOGY FOOTPRINT
12.5.5.4
BY END USER FOOTPRINT
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.6.1
PROGRESSIVE COMPANIES
12.6.2
RESPONSIVE COMPANIES
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
12.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
12.7
COMPANY VALUATION & FINANCIAL METRICS
12.8
BRAND/PRODUCT COMPARISON
12.9
R&D EXPENDITURE OF KEY PLAYERS
12.10
COMPETITIVE SCENARIO
12.10.1
PRODUCT LAUNCHES AND APPROVALS
12.10.4
OTHER DEVELOPMENTS
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
218
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS OFFERED
13.1.1.3
RECENT DEVELOPMENTS
13.1.1.3.1
PRODUCT LAUNCHES & APPROVALS
13.1.1.4.2
STRATEGIC CHOICES
13.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
13.1.4
TERUMO CORPORATION
13.1.6
MICROPORT SCIENTIFIC CORPORATION
13.1.8
KANEKA CORPORATION
13.1.9
PHENOX GMBH (WALLABY MEDICAL)
13.1.10
ASAHI INTECC CO., LTD
13.1.11
ACHIEVA MEDICAL (PEIJIA MEDICAL)
13.1.13
JAPAN LIFELINE CO., LTD
13.1.15
EVASC MEDICAL SYSTEM CORP
13.2.2
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
13.2.3
IMPERATIVE CARE, INC.
13.2.5
ZYLOX-TONBRIDGE MEDICAL CO., LTD.
13.3.1
NEUROSAFE MEDICAL CO., LTD
13.3.3
NEUROVASC TECHNOLOGIES, INC.
13.3.4
OXFORDENDOVASCULAR
13.3.5
GALAXY THERAPEUTICS
14
RESEARCH METHODOLOGY
286
14.1.1.1
KEY SOURCES OF SECONDARY DATA
14.1.1.2
KEY DATA FROM SECONDARY SOURCES
14.1.2.1
KEY PRIMARY SOURCES
14.1.2.2
OBJECTIVES OF PRIMARY RESEARCH
14.1.2.3
KEY DATA FROM PRIMARY SOURCES
14.1.2.4
KEY INDUSTRY INSIGHTS
14.1.2.5
BREAKDOWN OF PRIMARIES
14.2
MARKET SIZE ESTIMATION
14.4
MARKET SHARE ESTIMATION
14.5
RESEARCH ASSUMPTIONS
14.7
RESEARCH LIMITATIONS
14.7.1
SCOPE-RELATED LIMITATIONS
14.7.2
METHODOLOGY-RELATED LIMITATIONS
14.9
METHODOLOGY-RELATED LIMITATIONS
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
TABLE 1
STANDARD CURRENCY CONVERSION RATES
TABLE 2
NEUROVASCULAR DEVICES MARKET: UNMET NEEDS
TABLE 3
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
TABLE 4
NEUROVASCULAR DEVICES MARKET: PORTER’S FIVE FORCES
TABLE 5
GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030
TABLE 6
ROLE IN ECOSYSTEM: NEUROVASCULAR DEVICES MARKET
TABLE 7
AVERAGE SELLING PRICE TREND OF STENT RETRIEVERS, BY COMPANY, 2023–2025 (USD)
TABLE 8
AVERAGE SELLING PRICE TREND OF CAROTID ARTERY STENTS, BY COMPANY, 2023–2025 (USD)
TABLE 9
AVERAGE SELLING PRICE TREND OF ASPIRATION DEVICES, BY COMPANY, 2023–2025 (USD)
TABLE 10
AVERAGE SELLING PRICE TREND OF MICROCATHETERS, BY COMPANY, 2023–2025 (USD)
TABLE 11
AVERAGE SELLING PRICE TREND OF BALLOON CATHETERS, BY COMPANY, 2023–2025 (USD)
TABLE 12
AVERAGE SELLING PRICE TREND OF NEUROVASCULAR DEVICES, BY REGION, 2022–2024 (USD)
TABLE 13
IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 14
EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 15
NEUROVASCULAR DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 16
MEDTRONIC: FLOW DIVERTER FOR COMPLEX INTRACRANIAL ANEURYSMS
TABLE 17
PHENOX: ADVANCED FLOW DIVERTER WITH ENHANCED DELIVERABILITY
TABLE 18
STRYKER: STENT RETRIEVER THROMBECTOMY FOR ACUTE IN-STENT THROMBOSIS
TABLE 19
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 20
NEUROVASCULAR DEVICES MARKET: LIST OF MAJOR PATENTS, 2022–2025
TABLE 21
TOP USE CASES AND MARKET POTENTIAL
TABLE 22
NEUROVASCULAR DEVICES MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 23
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 24
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 29
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS BY DISEASE PATHOLOGY
TABLE 30
KEY BUYING CRITERIA FOR TOP APPLICATIONS
TABLE 31
ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 32
NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 33
NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 34
NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 36
EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 37
EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 38
BARE DETACHABLE COILS MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
COATED DETACHABLE COILS MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 40
FLOW DIVERSION DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 41
INTRACRANIAL STENTS MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
INTRACRANIAL STENTS MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 43
OTHER DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY REGION, 2023–2030 (USD MILLION)
TABLE 45
NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE 2023–2030 (USD MILLION)
TABLE 46
CLOT RETRIEVER DEVICES MARKET FOR ISCHEMIC STROKES, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
CLOT RETRIEVER DEVICES MARKET FOR ISCHEMIC STROKES, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 48
SUCTION & ASPIRATION DEVICES MARKET FOR ISCHEMIC STROKES, BY REGION, 2023–2030 (USD MILLION)
TABLE 49
VASCULAR SNARES MARKET FOR ISCHEMIC STROKES, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
BALLOON CATHETERS MARKET FOR ISCHEMIC STROKES, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
OTHER DEVICES MARKET FOR ISCHEMIC STROKES, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 54
CAROTID ARTERY STENTS MARKET FOR CAROTID ARTERY STENOSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 55
CAROTID ARTERY STENTS MARKET FOR CAROTID ARTERY STENOSIS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 56
EMBOLIC PROTECTION DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
BALLOON CATHETERS MARKET FOR CAROTID ARTERY STENOSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 58
NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 60
LIQUID EMBOLIC AGENTS MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2023–2030 (USD MILLION)
TABLE 61
OCCLUSION BALLOON CATHETERS MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2023–2030 (USD MILLION)
TABLE 62
MICROCATHETERS MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2023–2030 (USD MILLION)
TABLE 63
NEUROVASCULAR DEVICES MARKET FOR OTHER DISEASE PATHOLOGIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 65
NEUROVASCULAR DEVICES MARKET FOR HOSPITALS AND AMBULATORY SURGICAL CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 66
NEUROVASCULAR DEVICES MARKET FOR SPECIALTY CLINICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 67
NEUROVASCULAR DEVICES MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 68
NEUROVASCULAR DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 69
NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70
NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 71
NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, 2023–2030 (USD MILLION)
TABLE 72
NORTH AMERICA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 73
NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 74
NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 75
NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 76
NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 77
US: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 78
US: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, 2023–2030 (USD MILLION)
TABLE 79
US: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 80
US: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 81
US: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 82
US: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 83
US: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 84
CANADA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 85
CANADA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 86
CANADA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 87
CANADA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 88
CANADA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 89
CANADA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 90
CANADA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 91
EUROPE: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92
EUROPE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 93
EUROPE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 94
EUROPE: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 95
EUROPE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 96
EUROPE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 97
EUROPE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 98
EUROPE: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 99
GERMANY: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 100
GERMANY: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101
GERMANY: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 102
GERMANY: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 103
GERMANY: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 104
GERMANY: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105
GERMANY: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 106
FRANCE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 107
FRANCE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
FRANCE: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 109
FRANCE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 110
FRANCE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 111
FRANCE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
FRANCE: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 113
UK: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 114
UK: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
UK: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 116
UK: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 117
UK: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118
UK: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119
UK: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 120
ITALY: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 121
ITALY: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
ITALY: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 123
ITALY: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124
ITALY: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
ITALY: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
ITALY: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 127
SPAIN: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 128
SPAIN: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 129
SPAIN: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 130
SPAIN: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 131
SPAIN: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
SPAIN: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
SPAIN: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 134
REST OF EUROPE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 135
REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 136
REST OF EUROPE: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137
REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 138
REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
REST OF EUROPE: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 141
ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142
ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 143
ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
ASIA PACIFIC: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 145
ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146
ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147
ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 149
JAPAN: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 150
JAPAN: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
JAPAN: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 152
JAPAN: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153
JAPAN: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
JAPAN: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
JAPAN: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 156
CHINA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 157
CHINA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
CHINA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159
CHINA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160
CHINA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
CHINA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
CHINA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 163
INDIA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 164
INDIA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
INDIA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166
INDIA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
INDIA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
INDIA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
INDIA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 170
AUSTRALIA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 171
AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 172
AUSTRALIA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 173
AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174
AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
AUSTRALIA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 177
SOUTH KOREA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 178
SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179
SOUTH KOREA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
SOUTH KOREA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 184
REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 185
REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186
REST OF ASIA PACIFIC: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187
REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 191
LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 192
LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 193
LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
LATIN AMERICA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195
LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 199
BRAZIL: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 200
BRAZIL: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201
BRAZIL: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
BRAZIL: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 203
BRAZIL: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
BRAZIL: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 205
BRAZIL: NEUROVASCULAR DEVICES MARKET, BY END USER 2023–2030 (USD MILLION)
TABLE 206
MEXICO: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 207
MEXICO: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208
MEXICO: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 209
MEXICO: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 210
MEXICO: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
MEXICO: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
MEXICO: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 213
REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 214
REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215
REST OF LATIN AMERICA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 216
REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 220
MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY SUBREGION, 2023–2030 (USD MILLION)
TABLE 221
MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 222
MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223
MIDDLE EAST & AFRICA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 226
MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227
MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 228
GCC COUNTRIES: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 229
GCC COUNTRIES: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230
GCC COUNTRIES: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231
GCC COUNTRIES: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
GCC COUNTRIES: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233
GCC COUNTRIES: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234
GCC COUNTRIES: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 235
REST OF MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023–2030 (USD MILLION)
TABLE 236
REST OF MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 237
REST OF MIDDLE EAST & AFRICA: EMBOLIC COILS MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
REST OF MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239
REST OF MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
REST OF MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
REST OF MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 242
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NEUROVASCULAR DEVICES MARKET, JANUARY 2022–JUNE 2025
TABLE 243
NEUROVASCULAR DEVICE MARKET: DEGREE OF COMPETITION
TABLE 244
NEUROVASCULAR DEVICES MARKET: REGIONAL FOOTPRINT, 2024
TABLE 245
NEUROVASCULAR DEVICES MARKET: DISEASE PATHOLOGY FOOTPRINT, 2024
TABLE 246
NEUROVASCULAR DEVICES MARKET: BY END USER FOOTPRINT
TABLE 247
NEUROVASCULAR DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS, 2024
TABLE 248
NEUROVASCULAR DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT TYPE AND REGION, 2024
TABLE 249
NEUROVASCULAR DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025
TABLE 250
NEUROVASCULAR DEVICES MARKET: DEALS, JANUARY 2022–NOVEMBER 2025
TABLE 251
NEUROVASCULAR DEVICES MARKET: EXPANSIONS, JANUARY 2022–NOVEMBER 2025
TABLE 252
NEUROVASCULAR DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025
TABLE 253
STRYKER: COMPANY OVERVIEW
TABLE 254
STRYKER: PRODUCTS OFFERED
TABLE 255
STRYKER: PRODUCT LAUNCHES & APPROVALS
TABLE 257
STRYKER: EXPANSIONS
TABLE 258
MEDTRONIC: COMPANY OVERVIEW
TABLE 259
MEDTRONIC: PRODUCTS OFFERED
TABLE 260
MEDTRONIC: PRODUCT LAUNCHES & APPROVALS
TABLE 261
MEDTRONIC: EXPANSIONS
TABLE 262
JOHNSON & JOHNSON: BUSINESS OVERVIEW
TABLE 263
JOHNSON & JOHNSON: PRODUCTS OFFERED
TABLE 264
JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS
TABLE 265
JOHNSON & JOHNSON SERVICES, INC.: OTHER DEVELOPMENTS
TABLE 266
TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 267
TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 268
TERUMO CORPORATION: PRODUCT LAUNCHES & APPROVALS
TABLE 269
TERUMO CORPORATION: DEALS
TABLE 270
TERUMO CORPORATION: EXPANSIONS
TABLE 271
TERUMO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 272
PENUMBRA, INC.: COMPANY OVERVIEW
TABLE 273
PENUMBRA, INC.: PRODUCTS OFFERED
TABLE 274
PENUMBRA, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 275
MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 276
MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 277
MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS
TABLE 278
BALT GROUP: COMPANY OVERVIEW
TABLE 279
BALT GROUP: PRODUCTS OFFERED
TABLE 280
BALT GROUP: DEALS
TABLE 281
BALT GROUP: EXPANSIONS
TABLE 282
KANEKA CORPORATION: COMPANY OVERVIEW
TABLE 283
KANEKA CORPORATION: PRODUCTS OFFERED
TABLE 284
KANEKA CORPORATION: PRODUCT LAUNCHES & APPROVALS
TABLE 285
KANEKA CORPORATION: DEALS
TABLE 286
PHENOX GMBH (WALLABY MEDICAL): COMPANY OVERVIEW
TABLE 287
PHENOX GMBH (WALLABY MEDICAL): PRODUCTS OFFERED
TABLE 288
PHENOX GMBH (WALLABY MEDICAL): PRODUCT LAUNCHES & APPROVALS
TABLE 289
ASAHI INTECC CO., LTD.: COMPANY OVERVIEW
TABLE 290
ASAHI INTECC CO., LTD.: PRODUCTS OFFERED
TABLE 291
ASAHI INTECC CO., LTD: DEALS
TABLE 292
ASAHI INTECC CO., LTD: EXPANSIONS
TABLE 293
ACHIEVA MEDICAL (PEIJIA MEDICAL): COMPANY OVERVIEW
TABLE 294
ACHIEVA MEDICAL (PEIJIA MEDICAL): PRODUCTS OFFERED
TABLE 295
ACHIEVA MEDICAL (PEIJIA MEDICAL): DEALS
TABLE 296
RAPID MEDICAL: COMPANY OVERVIEW
TABLE 297
RAPID MEDICAL: PRODUCTS OFFERED
TABLE 298
RAPID MEDICAL: PRODUCT LAUNCHES & APPROVALS
TABLE 299
RAPID MEDICAL: DEALS
TABLE 300
JAPAN LIFELINE CO., LTD: COMPANY OVERVIEW
TABLE 301
JAPAN LIFELINE CO., LTD: PRODUCTS OFFERED
TABLE 302
ACANDIS GMBH: COMPANY OVERVIEW
TABLE 303
ACANDIS GMBH: PRODUCTS OFFERED
TABLE 304
ACANDIS GMBH: EXPANSIONS
TABLE 305
EVASC MEDICAL SYSTEM CORP: COMPANY OVERVIEW
TABLE 306
EVASC MEDICAL SYSTEM CORP: PRODUCTS OFFERED
TABLE 307
EVASC MEDICAL SYSTEM CORP: PRODUCT LAUNCHES & APPROVALS
TABLE 308
EVASC MEDICAL SYSTEM CORP: EXPANSIONS
TABLE 309
RESEARCH ASSUMPTIONS
TABLE 310
RISK ASSESSMENT
FIGURE 1
MARKETS COVERED & REGIONAL SCOPE
FIGURE 2
YEARS CONSIDERED
FIGURE 4
NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NEUROVASCULAR DEVICES MARKET
FIGURE 6
DISRUPTIVE TRENDS IMPACTING GROWTH OF NEUROVASCULAR DEVICES MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN NEUROVASCULAR DEVICES MARKET, 2024
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 9
INCREASE IN NUMBER OF DISEASES RELATED TO NEUROLOGICAL DISORDERS SUCH AS CEREBRAL ANEURYSMS AND STROKES TO DRIVE MARKET GROWTH
FIGURE 10
CEREBRAL ANEURYSMS SEGMENT ACCOUNTED FOR HIGHEST MARKET SHARE IN ASIA PACIFIC
FIGURE 11
CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 12
ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD, 2025–2030
FIGURE 13
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 14
DIABETES CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15
NEUROVASCULAR DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16
NEUROVASCULAR DEVICES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17
NEUROVASCULAR DEVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 18
NEUROVASCULAR DEVICES MARKET: ROLE IN ECOSYSTEM
FIGURE 19
NEUROVASCULAR DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20
NEUROVASCULAR DEVICES MARKET: FUNDING (USD MILLION) AND NUMBER OF DEALS, 2019–2023
FIGURE 21
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR NEUROVASCULAR DEVICES MARKET, JANUARY 2014–DECEMBER 2024
FIGURE 22
TOP PATENT APPLICANT COUNTRIES FOR NEUROVASCULAR DEVICES MARKET, JANUARY 2014–DECEMBER 2024
FIGURE 23
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS BY DISEASE PATHOLOGY
FIGURE 24
KEY BUYING CRITERIA, BY DISEASE PATHOLOGY
FIGURE 25
NEUROVASCULAR DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 26
NEUROVASCULAR DEVICES MARKET: NORTH AMERICA SNAPSHOT
FIGURE 27
NEUROVASCULAR DEVICES MARKET: ASIA PACIFIC SNAPSHOT
FIGURE 28
REVENUE SHARE ANALYSIS OF KEY PLAYERS IN NEUROVASCULAR DEVICES MARKET, 2022–2024 (USD MILLION)
FIGURE 29
MARKET SHARE ANALYSIS OF KEY PLAYERS IN NEUROVASCULAR DEVICES MARKET, 2024
FIGURE 30
NEUROVASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 31
NEUROVASCULAR DEVICES MARKET: COMPANY FOOTPRINT, 2024
FIGURE 32
NEUROVASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 33
EV/EBITDA OF KEY VENDORS, 2024
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
FIGURE 35
NEUROVASCULAR DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 36
NEUROVASCULAR DEVICES MARKET: R&D EXPENDITURE OF KEY PLAYERS, 2022–2024
FIGURE 37
STRYKER: COMPANY SNAPSHOT, 2024
FIGURE 38
MEDTRONIC: COMPANY SNAPSHOT, 2024
FIGURE 39
JOHNSON & JOHNSON: COMPANY SNAPSHOT, 2024
FIGURE 40
TERUMO CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 41
PENUMBRA, INC.: COMPANY SNAPSHOT, 2024
FIGURE 42
MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 43
KANEKA CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 44
ASAHI INTECC CO., LTD: COMPANY SNAPSHOT, 2024
FIGURE 45
JAPAN LIFELINE CO., LTD: COMPANY SNAPSHOT, 2024
FIGURE 46
RESEARCH DESIGN
FIGURE 47
NEUROVASCULAR DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 48
NEUROVASCULAR DEVICES MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDE)
FIGURE 49
KEY DATA FROM PRIMARY SOURCES
FIGURE 50
KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 51
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 52
BREAKDOWN OF PRIMARY INTERVIEWS, BY END USER, DESIGNATION, AND REGION
FIGURE 53
MARKET SIZE ESTIMATION PROCESS THROUGH REVENUE DATA
FIGURE 54
US: REVENUE SHARE ANALYSIS FOR STRYKER, 2024
FIGURE 55
SUPPLY SIDE ANALYSIS, 2024
FIGURE 56
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 57
BOTTOM-UP APPROACH
FIGURE 58
CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS, 2025–2030
FIGURE 59
TOP-DOWN APPROACH
FIGURE 60
DATA TRIANGULATION METHODOLOGY
FIGURE 61
FACTOR ANALYSIS
Lester
May, 2022
need data on advancements in the Neurovascular Devices market. outlook, size, share everything..
Jamie
May, 2022
Detailed US geo information of Neurovascular Devices Market with a vision to 2022 - 2026.
Joseph
Jun, 2026
After reviewing the Neurovascular Devices Market report, I noticed how the increasing shift toward minimally invasive neurointerventional procedures is reshaping hospital procurement priorities and physician training requirements..
Scarlett
Jun, 2026
From a technical lens, the Neurovascular Devices Market highlights continuous improvements in catheter design and imaging compatibility, which are critical for navigating complex vascular structures with higher precision..
Matthew
Jun, 2026
Looking at market dynamics, my takeaway from the Neurovascular Devices Market is that growth will be strongly influenced by stroke management protocols and the expansion of specialized neurointervention centers globally..
Douglas
Mar, 2022
In what way COVID19 is Impacting the global growth of the Neurovascular Devices Market?.